Prognostic significance of cardiorenal dysfunction within 1 year after atrial fibrillation ablation in patients with systolic dysfunction

被引:1
作者
Koike, Toshiharu [1 ]
Ejima, Koichiro [1 ,2 ]
Kataoka, Shohei [1 ]
Yazaki, Kyoichiro [1 ]
Higuchi, Satoshi [1 ]
Kanai, Miwa [1 ]
Yagishita, Daigo [1 ,2 ]
Shoda, Morio [1 ,2 ]
Hagiwara, Nobuhisa [1 ]
机构
[1] Tokyo Womens Med Univ, Dept Cardiol, Sch Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan
[2] Tokyo Womens Med Univ, Dept Cardiol, Clin Res Div Heart Rhythm Management, Tokyo, Japan
关键词
Atrial fibrillation; Catheter ablation; Left ventricular ejection fraction; Renal function; WORSENING RENAL-FUNCTION; EXPERT CONSENSUS STATEMENT; CHRONIC KIDNEY-DISEASE; HEART-FAILURE; CATHETER ABLATION; SURGICAL ABLATION; EJECTION FRACTION; FOLLOW-UP; IMPACT; RECOMMENDATIONS;
D O I
10.1007/s00380-022-02124-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial fibrillation (AF) ablation can improve left ventricular ejection fraction (LVEF) and renal function and can even reduce mortality in patients with impaired LVEF. However, the effect of post-ablation cardiorenal dysfunction on the prognosis of patients with impaired LVEF who underwent AF ablation remains unclear. Of the 1243 consecutive patients undergoing AF ablation, the prognosis of 163 non-dialysis patients who underwent AF ablation with < 50% LVEF was evaluated. The primary outcome was a composite of all-cause mortality, heart failure hospitalization, and a need for modification of the treatment for heart failure. During the median follow-up of 4.2 years after the first AF ablation procedure, the primary outcome occurred in 30 of 163 patients (18%). The receiver operating characteristic curve analysis demonstrated that the post-LVEF (LVEF within 1 year after the procedure, and before the occurrence of primary outcome) had larger areas under the curve (0.70) than the pre-LVEF (LVEF before the procedure), and the most optimal cutoff value was LVEF <= 42%. Multivariate analysis demonstrated that patients with post-LVEF <= 42% and worsening renal function (WRF; an absolute increase in serum creatinine [SCr] >= 0.3 mg/dL compared with the SCr at baseline within 1 year after the procedure and before the occurrence of primary outcome) had a 3.4- to 4.3-fold and 3.4- to 3.7-fold higher risk of the primary outcome compared with those without these predictors, respectively. Patients were categorized using post-LVEF <= 42% and WRF as follows: group 1 (post-LVEF > 42% without WRF), group 2 (post-LVEF <= 42% without WRF), group 3 (post-LVEF > 42% with WRF), and group 4 (post-LVEF <= 42% with WRF). Group 4 had a 15.8-fold (P = 0.0001) higher risk of the primary outcome compared with group 1 after adjusting for pre-procedural factors. In patients with impaired LVEF undergoing AF ablation, post-LVEF <= 42% and WRF were independent predictors of poor prognosis. The combination of post-LVEF <= 42% and WRF is strongly associated with a poor prognosis in patients with AF undergoing ablation, who with these post-ablation cardiorenal dysfunction may have to be treated more intensively after AF ablation.
引用
收藏
页码:77 / 89
页数:13
相关论文
共 33 条
  • [1] Prevalence of Atrial Fibrillation and Its Predictors in Nondialysis Patients with Chronic Kidney Disease
    Ananthapanyasut, Wanwarat
    Napan, Sirikarn
    Rudolph, Earl H.
    Harindhanavudhi, Tasma
    Ayash, Husam
    Guglielmi, Kelly E.
    Lerma, Edgar V.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (02): : 173 - 181
  • [2] Mortality of newly diagnosed heart failure treated with amiodarone A propensity-matched study
    Andrey, Jose L.
    Gomez-Soto, Francisco M.
    Romero, Sotero P.
    Escobar, Miguel A.
    Antonio Garcia-Egido, A.
    Garcia-Arjona, Rocio
    Gomez, Francisco
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 151 (02) : 175 - 181
  • [3] Atrial Fibrillation and Heart Failure Treatment Considerations for a Dual Epidemic
    Anter, Elad
    Jessup, Mariell
    Callans, David J.
    [J]. CIRCULATION, 2009, 119 (18) : 2516 - 2525
  • [4] HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up
    Calkins, Hugh
    Brugada, Josep
    Packer, Douglas L.
    Cappato, Riccardo
    Chen, Shih-Ann
    Crijns, Harry J. G.
    Damiano, Ralph J., Jr.
    Davies, D. Wyn
    Haines, David E.
    Haissaguerre, Michel
    Iesaka, Yoshito
    Jackman, Warren
    Jais, Pierre
    Kottkamp, Hans
    Kuck, Karl Heinz
    Lindsay, Bruce D.
    Marchlinski, Francis E.
    McCarthy, Patrick M.
    Mont, J. Lluis
    Morady, Fred
    Nademanee, Koontawee
    Natale, Andrea
    Pappone, Carlo
    Prystowsky, Eric
    Raviele, Antonio
    Ruskin, Jeremy N.
    Shemin, Richard J.
    [J]. HEART RHYTHM, 2007, 4 (06) : 816 - 861
  • [5] Calkins H, 2017, HEART RHYTHM, V14, pE445, DOI [10.1093/europace/eux275, 10.1016/j.hrthm.2017.07.009, 10.1016/j.hrthm.2017.05.012]
  • [6] 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design
    Calkins, Hugh
    Kuck, Karl Heinz
    Cappato, Riccardo
    Brugada, Josep
    Camm, A. John
    Chen, Shih-Ann
    Crijns, Harry J. G.
    Damiano, Ralph J., Jr.
    Davies, D. Wyn
    DiMarco, John
    Edgerton, James
    Ellenbogen, Kenneth
    Ezekowitz, Michael D.
    Haines, David E.
    Haissaguerre, Michel
    Hindricks, Gerhard
    Iesaka, Yoshito
    Jackman, Warren
    Jalife, Jose
    Jais, Pierre
    Kalman, Jonathan
    Keane, David
    Kim, Young-Hoon
    Kirchhof, Paulus
    Klein, George
    Kottkamp, Hans
    Kumagai, Koichiro
    Lindsay, Bruce D.
    Mansour, Moussa
    Marchlinski, Francis E.
    McCarthy, Patrick M.
    Mont, J. Lluis
    Morady, Fred
    Nademanee, Koonlawee
    Nakagawa, Hiroshi
    Natale, Andrea
    Nattel, Stanley
    Packer, Douglas L.
    Pappone, Carlo
    Prystowsky, Eric
    Raviele, Antonio
    Reddy, Vivek
    Ruskin, Jeremy N.
    Shemin, Richard J.
    Tsao, Hsuan-Ming
    Wilber, David
    Ad, Niv
    Cummings, Jennifer
    Gillinov, A. Mark
    Heidbuchel, Hein
    [J]. EUROPACE, 2012, 14 (04): : 528 - 606
  • [7] Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme
    Damman, Kevin
    Solomon, Scott D.
    Pfeffer, Marc A.
    Swedberg, Karl
    Yusuf, Salim
    Young, James B.
    Rouleau, Jean L.
    Granger, Christopher B.
    McMurray, John J. V.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (12) : 1508 - 1517
  • [8] Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
    Damman, Kevin
    Valente, Mattia A. E.
    Voors, Adriaan A.
    O'Connor, Christopher M.
    van Veldhuisen, Dirk J.
    Hillege, Hans L.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (07) : 455 - +
  • [9] Eknoyan G., 2013, Kidney Int Suppl, V3, P5
  • [10] Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure
    Forman, DE
    Butler, J
    Wang, YF
    Abraham, WT
    O'Connor, CM
    Gottlieb, SS
    Loh, E
    Massie, BM
    Rich, MW
    Stevenson, LW
    Young, JB
    Krumholz, HM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (01) : 61 - 67